CMA1 and renal fibrosis: Since TY-51469 treatment suppressed both chymase-positive mast cell accumulation and MMCP-4 gene expression, which correlated with reduced fibrosis, it is likely that chymase activation indeed played a role in the pathogenesis of renal fibrosis in this model.